Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate
Clinical trial NCT00385840 · COMPLETED
Trial details
- NCT number
- NCT00385840
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-20
- Primary completion
- 2007-02-01
- Enrollment
- 678
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.